Assessement of the combination of iron oxide nanoparticles and erastin to radiosensitize head and neck cancer cells (EACR 2025) - Jun 29, 2025 - Abstract #P-523; Pres time: Jul 17, 2025; 10:45 AM - 08:00 PM; Location: Poster and Exhibition Hall; Poster Board No EACR25-2154; "These findings highlight the promising role of IONPs and erastin in HNC treatment. Further investigations integrating radiotherapy are necessary to confirm their radiosensitizing potential and to elucidate the underlying molecular pathways, particularly ferroptosis induction."
Head and Neck Cancer • Oncology • Solid Tumor
|
|
D. Sant'Angelo 1; G. Descamps 2; F. Bouffioux 1; V. Lecomte 2; D. Stanicki 2; L. Verset 3; S. Saussez 4; S. Laurent 2; J. Colet 1; F. Journe 5
|